Chronic corticotropin-releasing hormone and vasopressin regulate corticosteroid receptors in rat hippocampus and anterior pituitary

Brain Research

Volumn 976, Issue 2, 2003, Pages 159-170

  Hügin Flores, Mirza E ^a   Steimer, Thierry ^a   Schulz, Pierre ^a   Vallotton, Michel B ^a   Aubert, Michel L ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Anterior pituitary; Corticotropin releasing hormone; Glucocorticoid receptor; Hippocampus; Mineralocorticoid receptor; Vasopressin

Indexed keywords

CORTICOSTEROID RECEPTOR; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; MESSENGER RNA; VASOPRESSIN; VASOPRESSIN ANTAGONIST;

ADAPTATION; ADENOHYPOPHYSIS; ALPHA HELIX; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG INFUSION; HIPPOCAMPUS; HORMONE BINDING; IMMOBILIZATION STRESS; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REGULATORY MECHANISM; STRESS;

EID: 17144469387     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02585-X     Document Type: Article

References (68)

1. Albeck D.S., McKittrick C.R., Blanchard D.C., Blanchard R.J., Nikulina J., McEwen B.S., Sakai R.R. Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain. J. Neurosci. 17:1997;4895-4903.
2. Alema G.S., Casolini P., Patacchioli F.R., Angelucci L. Rat brain corticosteriod receptors are modulated by septo-hippocampal cholinergic innervation. Neuroreport. 6:1995;2461-2464.
3. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160:1999;1-12.
4. Barberis C., Tribollet E. Vasopressin and oxytocin receptors in the central nervous system. Crit Rev. Neurobiol. 10:1996;119-154.
5. Bartanusz V., Jezova D., Bertini L.T., Tilders F.J., Aubry J.M., Kiss J.Z. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology. 132:1993;895-902.
6. Buwalda B., de Boer S.F., Van Kalkeren A.A., Koolhaas J.M. Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrinology. 22:1997;297-309.
7. Calabrese E.J., Baldwin L.A. Hormesis: U-shaped dose responses and their centrality in toxicology. Trends Pharmacol. Sci. 22:2001;285-291.
8. Casolini P., Piazza P.V., Kabbaj M., Leprat F., Angelucci L., Simon H., Le Moal M., Maccari S. The mesolimbic dopaminergic system exerts an inhibitory influence on brain corticosteroid receptor affinities. Neuroscience. 55:1993;429-434.
9. Catzeflis C., Pierroz D.D., Rohner-Jeanrenaud F., Rivier J.E., Sizonenko P.C., Aubert M.L. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. Endocrinology. 132:1993;224-234.
10. Chao H.M., Choo P.H., McEwen B.S. Glucocorticoid and mineralocorticoid receptor mRNA expression in rat brain. Neuroendocrinology. 50:1989;365-371.
11. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., Nemeroff C.B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci. 6:1986;2908-2914.
12. Chen X., Herbert J. Alterations in sensitivity to intracerebral vasopressin and the effects of a V1a receptor antagonist on cellular, autonomic and endocrine responses to repeated stress. Neuroscience. 64:1995;687-697.
13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
14. Conrad C.D., Lupien S.J., McEwen B.S. Support for a bimodal role for type II adrenal steroid receptors in spatial memory. Neurobiol. Learn. Mem. 72:1999;39-46.
15. Dallman M.F., Akana S.F., Cascio C.S., Darlington D.N., Jacobson L., Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog. Horm. Res. 43:1987;113-173.
16. Dautzenberg F.M., Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23:2002;71-77.
17. de Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19:1998;269-301.
18. de Wied D., Diamant M., Fodor M. Central nervous system effects of the neurohypophyseal hormones and related peptides. Front. Neuroendocrinol. 14:1993;251-302.
19. Diamant M., de Wied D. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats. Endocrinology. 129:1991;446-454.
20. Diamant M., de Wied D. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats. Am. J. Physiol. 264:1993;R51-R61.
21. Diaz Brinton R., Brownson E.A. Vasopressin-induction of cyclic AMP in cultured hippocampal neurons. Brain Res. Dev. Brain Res. 71:1993;101-105.
22. Dong Y., Aronsson M., Gustafsson J.A., Okret S. The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. J. Biol. Chem. 264:1989;13679-13683.
23. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Brain Res. Rev. 15:1990;71-100.
24. Fisher L., Rivier C., Rivier J., Brown M. Differential antagonist activity of α-helical corticotropin-releasing factor 9-41 in three bioassay systems. Endocrinology. 129:1991;1312-1316.
25. Gesing A., Bilang-Bleuel A., Droste S.K., Linthorst A.C., Holsboer F., Reul J.M. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone. J. Neurosci. 21:2001;4822-4829.
26. Givalois L., Arancibia S., Tapia-Arancibia L. Concomitant changes in CRH mRNA levels in rat hippocampus and hypothalamus following immobilization stress. Brain Res. Mol. Brain Res. 75:2000;166-171.
27. Gwosdow-Cohen A., Chen C.L., Besch E.L. Radioimmunoassay (RIA) of serum corticosterone in rats. Proc. Soc. Exp. Biol. Med. 170:1982;29-34.
28. Hauger R.L., Millan M.A., Lorang M., Harwood J.P., Aguilera G. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress. Endocrinology. 123:1988;396-405.
29. Herman J.P., Adams D., Prewitt C. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology. 61:1995;180-190.
30. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20:1997;78-84.
31. Herman J.P., Spencer R. Regulation of hippocampal glucocorticoid receptor gene transcription and protein expression in vivo. J. Neurosci. 18:1998;7462-7473.
32. Herman J.P., Watson S.J., Spencer R.L. Defense of adrenocorticosteroid receptor expression in rat hippocampus: effects of stress and strain. Endocrinology. 140:1999;3981-3991.
33. Hügin-Flores M.E., Steimer T., Hof M., Vallotton M.B., Aubert M.L. Adaptation to chronic immobilization stress in rats: corticosteroid receptors and behavioural studies. IV European Congress of Endocrinology (Abstract 249) :1998.
34. Hügin-Flores M.E., Steimer T., Vallotton M.B., Aubert M.L. Effect of chronic immobilization stress on type I and type II corticosteroid receptor gene expression. 80th Annual Meeting of the Endocrine Society, New Orleans, LA (Abstract 402) :1998.
35. Imaki T., Nahan J.L., Rivier C., Sawchenko P.E., Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci. 11:1991;585-599.
36. Jacobson L., Akana S.F., Cascio C.S., Shinsako J., Dallman M.F. Circadian variations in plasma corticosterone permit normal termination of adrenocorticotropin responses to stress. Endocrinology. 122:1988;1343-1348.
37. Jezova D., Ochedalski T., Glickman M., Kiss A., Aguilera G. Central corticotropin-releasing hormone receptors modulate hypothalamic-pituitary-adrenocortical and sympathoadrenal activity during stress. Neuroscience. 94:1999;797-802.
38. Joels M., de Kloet E.R. Control of neuronal excitability by corticosteroid hormones. Trends Neurosci. 15:1992;25-30.
39. Kasckow J.W., Baker D., Geracioti T.D. Jr. Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides. 22:2001;845-851.
40. Korte S.M., Korte-Bouws G.A., Bohus B., Koob G.F. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats. Physiol. Behav. 56:1994;115-120.
41. Liang K.C., Melia K.R., Miserendino M.J., Falls W.A., Campeau S., Davis M. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. J. Neurosci. 12:1992;2303-2312.
42. Ma X.M., Lightman S.L. The arginine vasopressin and corticotrophin-releasing hormone gene transcription responses to varied frequencies of repeated stress in rats. J. Physiol. 510:(Pt. 2):1998;605-614.
43. Maccari S., Mormede P., Piazza P.V., Simon H., Angelucci L., Le Moal M. Hippocampal type I and type II corticosteroid receptors are modulated by central noradrenergic systems. Psychoneuroendocrinology. 17:1992;103-112.
44. Makino S., Smith M.A., Gold P.W. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. Endocrinology. 136:1995;3299-3309.
45. Mamalaki E., Kvetnansky R., Brady L.S., Gold P.W., Herkenham M. Repeated immobilization stress alters tyrosine hydroxylase, corticotropin-releasing hormone and corticosteroid receptor messenger ribonucleic acid levels in rat brain. J. Neuroendocrinol. 4:1993;689-699.
46. Mormede P. The vasopressin receptor antagonist dPTyr (Me) AVP does not prevent stress-induced ACTH and corticosterone release. Nature. 302:1983;345-346.
47. Muller M.B., Landgraf R., Keck M.E. Vasopressin, major depression, and hypothalamic-pituitary-adrenocortical desensitization. Biol. Psychiatry. 48:2000;330-333.
48. Nikodemova M., Diehl C.R., Aguilera G. Multiple sites of control of type-1 corticotropin releasing hormone receptor levels in the pituitary. Arch. Physiol. Biochem. 110:2002;123-128.
49. Rabadan-Diehl C., Lolait S.J., Aguilera G. Regulation of pituitary vasopressin V1b receptor mRNA during stress in the rat. J. Neuroendocrinol. 7:1995;903-910.
50. Radulovic J., Ruhmann A., Liepold T., Spiess J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J. Neurosci. 19:1999;5016-5025.
51. Reul J.M., Pearce P.T., Funder J.W., Krozowski Z.S. Type I and type II corticosteroid receptor gene expression in the rat: effect of adrenalectomy and dexamethasone administration. Mol. Endocrinol. 3:1989;1674-1680.
52. Sapolsky R.M., Krey L.C., McEwen B.S. Stress downregulates corticosterone receptors in a site-specific manner in the brain. Endocrinology. 114:1984;287-292.
53. Sapolsky R.M., Krey L.C., McEwen B.S., Rainbow T.C. Do vasopressin-related peptides induce hippocampal corticosterone receptors? Implications for aging. J. Neurosci. 4:1984;1479-1485.
54. Semont A., Fache M., Ouafik L., Hery M., Faudon M., Hery F. Effect of serotonin inhibition on glucocorticoid and mineralocorticoid expression in various brain structures. Neuroendocrinology. 69:1999;121-128.
55. Sheppard K.E. Calcium and protein kinase C regulation of the glucocorticoid receptor in mouse corticotrope tumor cells. J. Steroid Biochem. Mol. Biol. 48:1994;337-345.
56. Sheppard K.E., Roberts J.L., Blum M. Differential regulation of type II corticosteroid receptor messenger ribonucleic acid expression in the rat anterior pituitary and hippocampus. Endocrinology. 127:1990;431-439.
57. Sheppard K.E., Roberts J.L., Blum M. Adrenocorticotropin-releasing factor downregulates glucocorticoid receptor expression in mouse corticotrope tumor cells via an adenylate cyclase-dependent mechanism. Endocrinology. 129:1991;663-670.
58. Spencer R.L., McEwen B.S. Adaptation of the hypothalamic-pituitary-adrenal axis to chronic ethanol stress. Neuroendocrinology. 52:1990;481-489.
59. Spencer R.L., Young E.A., Choo P.H., McEwen B.S. Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid. Brain Res. 514:1990;37-48.
60. Tizabi Y., Aguilera G. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin. Neuroendocrinology. 56:1992;611-618.
61. van Londen L., Goekoop J.G., van Kempen G.M., Frankhuijzen-Sierevogel A.C., Wiegant V.M., van der Velde E.A., de Wied D. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology. 17:1997;284-292.
62. Veldhuis H.D., de Kloet E.R. Vasopressin-related peptides increase the hippocampal corticosterone receptor capacity of diabetes insipidus (Brattleboro) rats. Endocrinology. 110:1982;153-157.
63. Wang H.L., Wayner M.J., Chai C.Y., Lee E.H. Corticotrophin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus. Eur. J. Neurosci. 10:1998;3428-3437.
64. Winslow J.T., Newman J.D., Insel T.R. CRH and α-helical-CRH modulate behavioral measures of arousal in monkeys. Pharm. Biochem. Behav. 32:1989;919-926.
65. Wong M.L., Webster E.L., Spokes H., Phu P., Ehrhart-Bornstein M., Bornstein S., Park C.S., Rice K.C., Chrousos G.P., Licinio J., Gold P.W. Chronic administration of the nonpeptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. Life Sci. 65:1999;L53-L58.
66. Wotjak C.T., Kubota M., Liebsch G., Montkowski A., Holsboer F., Neumann I., Landgraf R. Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion? J. Neurosci. 16:1996;7725-7732.
67. Yehuda R. Biology of post-traumatic stress disorder. J. Clin. Psychiatry. 62:(Suppl. 17):2001;41-46.
68. Young E.A., Spencer R.L., McEwen B.S. Changes at multiple levels of the hypothalamo-pituitary adrenal axis following repeated electrically induced seizures. Psychoneuroendocrinology. 15:1990;165-172.